Skip to main content

Table 2 Multilevel logistic regressions in CHD patients (dependent variable: adherence to disease management quality indicators)

From: Prevalence of chronic diseases by immigrant status and disparities in chronic disease management in immigrants: a population-based cohort study, Valore Project

  

OR

95%LL

95%UL

p

Therapy with ACE inhibitors

     

Nationality (Italian = reference)

HDC

0.73

0.55

0.97

0.03

 

HMPC

0.58

0.50

0.67

0.00

Therapy with anti-thrombotic agents

     

Nationality (Italian = reference)

HDC

1.02

0.76

1.39

0.86

 

HMPC

0.59

0.50

0.68

0.00

Annual total cholesterol monitoring

     

Nationality (Italian = reference)

HDC

0.84

0.63

1.12

0.23

 

HMPC

0.47

0.40

0.54

0.00

  1. All regressions adjusted for gender, age band (16–44, 45–64, 65–74, 75–84, > 85 years), time since diagnosis (dichotomized as ≤3y and >3y), and the Charlson index on a first level, and health districts on a second level.